Key information

Application number
202612969
Trademark text
RETHYMIC CONNECT
Case type
International registration designating Norway
Status
22.10.2026 Mottatt
Notification date
22.10.2026
Priority
28.05.2026 JP 2026-060810
International registration number
1944735 Check status in WIPO
International registration date
17.06.2026
Renewal deadline
17.06.2036
Trademark category
Trademark
Type of Mark
Word Mark
Goods/services (NICE class)
35, 41, 44, 45
Acquired distinctiveness
No
Applicant
Sumitomo Pharma Co., Ltd. (JP)
Owner
Sumitomo Pharma Co., Ltd. (JP)

List of products


Class 35
Operation of businesses for others in the field of healthcare; healthcare operations management services, namely, connecting patients to qualified healthcare resources in the nature of administrative services relating to the referral of patients.
Class 41
Educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops in the health and medical field; educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops in the field of pharmaceutical, biomedical and biological therapeutic research; educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops for patients and their families and caregivers regarding the diagnosis, treatment and care of rare diseases and disorders and immunological diseases and disorders; healthcare education.
Class 44
Providing health information and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; providing information to patients and their families and caregivers relating to the diagnosis, treatment and care of patients with rare diseases and disorders and immunological diseases and disorders; medication management and disease management being health care; patient advocacy services being advocacy services relating to health issues.
Class 45
Patient advocacy services being legal advocacy services; non-therapeutic customized support counseling for patients with congenital athymia; providing emotional support for patients and their families via interactive on-line forums; providing companionship services for families of patients with threatening disorders.

Documents


Download files (1)
Date
Date Doc. No. Process Case number In/Out Journal description To/from
23.10.2026 01-01 Saksbehandling 202612969(1944735) INN N202641_133 BIRTH ENN WIPO/PCT

Priority


28.05.2026 JP 2026-060810

Applicants and owners


Owners
Sumitomo Pharma Co., Ltd.
6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0045 JP

Agent


No agent

Status history


Payment history


Most fees for international trademarks and designs are paid to WIPO.

Oppositions and appeals


No oppositions or appeals

Alteration of mark


No alteration of mark

Liens and licences


No liens or licenses registered

Gazette entries


No Gazette entries foundOnly events from 2024.03.04 and onwards are shown.